Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Common stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total
Balance at Dec. 31, 2023	$ 11	$ 3,145,837	$ (2,377,436)	$ (3,085)	$ 765,327
Balance (in shares) at Dec. 31, 2023	119,581
Issuance of common stock upon exercise of stock options		6,466			6,466
Issuance of common stock upon exercise of stock options (in shares)	792
Issuance of common stock for bonus		24,071			24,071
Issuance of common stock for bonus (in shares)	270
Vesting of restricted stock units	$ 1				1
Vesting of restricted stock units (in shares)	1,591
Stock based compensation		64,952			64,952
Unrealized gain loss on available-for sale securities				893	893
Net loss			(67,599)		(67,599)
Balance at Mar. 31, 2024	$ 12	3,241,326	(2,445,035)	(2,192)	794,111
Balance (in shares) at Mar. 31, 2024	122,234
Balance at Dec. 31, 2024	$ 12	3,763,614	(2,567,862)	(344)	$ 1,195,420
Balance (in shares) at Dec. 31, 2024	132,646				132,646
Issuance of common stock upon exercise of stock options		544			$ 544
Issuance of common stock upon exercise of stock options (in shares)	50
Issuance of common stock for bonus		32,063			32,063
Issuance of common stock for bonus (in shares)	222
Vesting of restricted stock units	$ 2				2
Vesting of restricted stock units (in shares)	3,014
Stock based compensation		78,435			78,435
Unrealized gain loss on available-for sale securities				147	147
Net loss			(66,936)		(66,936)
Balance at Mar. 31, 2025	$ 14	$ 3,874,656	$ (2,634,798)	$ (197)	$ 1,239,675
Balance (in shares) at Mar. 31, 2025	135,932				135,932